Investor Rimon Gold Assets Ltd
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Rimon Gold Assets Ltd . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2024-12-09 13G NRSN / NeuroSense Therapeutics Ltd. 2,303,729
2021-02-16 13D/A / Mawson Infrastructure Group Inc. 6,966,414 6,927,866
2020-03-05 13D/A / Wize Pharma Inc 42,006,847 6,966,414
2017-11-28 13D / Wize Pharma Inc 42,006,847
2017-11-27 13D OPLI / OphthaliX Inc. 42,006,847